[Skip to Content]
[Skip to Content Landing]

Perioperative Cardiac Risk Assessment

Learning Objectives
1. Tailor the perioperative evaluation based on the urgency of the procedure
2. Determine if there are red flag issues that may necessitate delaying nonemergent surgery
3. Estimate the combined clinical/surgical risk based on validated modules
4. Determine functional status using metabolic equivalents
5. Assess the appropriate uses for cardiac stress testing and coronary revascularization
6. Evaluate the role of the perioperative biomarkers for cardiac risk assessment
2 Credits CME

Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient with the option of surgery. To assess for the preoperative cardiac risk, hospitalists should follow a step-wise algorithm. The following module reviews the risk assessment process and enables the hospitalist to order appropriate preoperative testing.

Please finish the activity before taking the quiz.
Close

Sign in to take quiz and track your certificates

Society of Hospital Medicine Education

SHM Consults: Perioperative And Consultative Medicine curriculum can help you feel more confident about your knowledge and skills related to consultative medicine. Learn more

Activity Information

Accreditation Statement: The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement Designation: The Society of Hospital Medicine designates this activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Author: Dr. Cohn reports owning stock in AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline, Merck & Co, Inc, Pfizer Inc, and Portola; and reports serving on the speakers bureau for Janssen and Portola. Editors (Leonard Feldman, MD, FACP, SFHM and Kurt Pfifer, MD, FACP, SFHM) Dr. Feldman reports having no relevant financial or advisory relationships with corporate organizations related to this activity. Dr. Pfeifer reports having no relevant financial or advisory relationships with corporate organizations related to this activity. The planners and faculty for this activity have no relevant relationships to disclose unless otherwise listed.

SHM COI Policy: In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity. Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

References:
1.
Cohen  MC, Aretz  TH.  Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction.  Cardiovasc Pathol. 1999;8:133–139.Google Scholar
2.
Dawood  MM, Gutpa  DK, Southern  J,  et al.  Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention.  Int J Cardiol. 1996;57:37–44.Google Scholar
3.
Beaupre  LA, Jones  CA, Saunders  LD,  et al.  Best practices for elderly hip fracture patients. A systematic overview of the evidence.  J Gen Intern Med. 2005;20:1019–1025.Google Scholar
4.
Bottle  A, Aylin  P.  Mortality associated with delay in operation after hip fracture: observational study.  BMJ. 2006;332:947–951.Google Scholar
5.
Fleisher  LA, Fleischmann  KE, Auerbach  AD,  et al.  2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.  J Am Coll Cardiol. 2014;64:e77–e137.Google Scholar
6.
Fleisher  LA, Beckman  JA, Brown  KA,  et al.  ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.  Circulation. 2007;116:e418–e499.Google Scholar
7.
Amsterdam  EA, Wenger  NK, Brindis  RG,  et al.  2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.  J Am Coll Cardiol. 2014;64:e139–e228.Google Scholar
8.
O'Gara  PT, Kushner  FG, Ascheim  DD,  et al; American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  J Am Coll Cardiol. 2013;61:e78–e140.Google Scholar
9.
Nuttall  GA, Brown  MJ, Stombaugh  JW,  et al.  Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.  Anesthesiology. 2008;109:588–595.Google Scholar
10.
Rabbitts  JA, Nuttall  GA, Brown  MJ,  et al.  Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.  Anesthesiology. 2008;109:596–604.Google Scholar
11.
Pfisterer  M, Brunner-La Rocca  HP, Buser  PT,  et al.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drugeluting versus bare-metal stents.  J Am Coll Cardiol. 2006;48:2584–2591.Google Scholar
12.
Grines  CL, Bonow  RO, Casey  DE  Jr,  et al; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians.  Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.  J Am Coll Cardiol. 2007;49:734–739.Google Scholar
13.
Douketis  JD, Spyropoulos  AC, Spencer  FA,  et al; American College of Chest Physicians.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.  Chest. 2012;141(2 Suppl):e326s–3250s.Google Scholar
14.
Wijns  W,  et al; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI),  Guidelines on myocardial revascularization.  Eur Heart J. 2010;31:2501–2555.Google Scholar
15.
Tanguay  JF, Bell  AD, Ackman  ML,  et al.  Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy.  Can J Cardiol. 2013. doi:pii: S0828-282X(13)00443-1.Google Scholar
16.
Darvish-Kazem  S, Gandhi  M, Marcucci  M,  et al.  Perioperative Management of Antiplatelet Therapy in Patients with a Coronary Stent who Need Non-cardiac Surgery: A Systematic Review of Clinical Practice Guidelines.  Chest. 2013.Google Scholar
17.
Wijeysundera  DN, Wijeysundera  HC, Yun  L,  et al.  Risk of elective major noncar iac surgery after coronary stent insertion: a population-based study.  Circulation. 2012;126:1355–1362.Google Scholar
18.
Hawn  MT, Graham  LA, Richman  JS,  et al.  Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.  JAMA. 2013;310:1462–1472.Google Scholar
19.
Schein  OD, Katz  J, Bass  EB,  et al.  The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery.  N Engl J Med. 2000;342:168–175.Google Scholar
20.
Lindenauer  PK, Pekow  P, Wang  K,  et al.  Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.  JAMA. 2004;291:2092–2099.Google Scholar
21.
Hlatky  MA, Boineau  RE, Higginbotham  MB,  et al.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index).  Am J Cardiol. 1989;64:651–654.Google Scholar
22.
University of South Carolina Arnold School of Public Health.  The Compendium of Physical Activities Tracking Guide.  Available at: http://prevention.sph.sc.edu/tools/docs/documents_compendium.pdf. Published 2000.
23.
Centers for Disease Control and Prevention – Division of Nutrition, Physical Activity, and Obesity.  General Physical Activities Defined by Level of Intensity.  Available at: http://www.cdc.gov/nccdphp/dnpa/physical/pdf/PA_Intensity_table_2_1.pdf.
24.
Goldman  L, Caldera  DL, Nussbaum  SR,  et al.  Multifactorial index of cardiac risk in noncardiac surgical procedures.  N Engl J Med. 1977;297:845–850.Google Scholar
25.
Lee  TH, Marcantonio  ER, Mangione  CM,  et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.  Circulation. 1999;100:1043– 1049.Google Scholar
26.
Boersma  E, Kertai  MD, Schouten  O,  et al.  Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index.  Am J Med. 2005;118:1134–1141.Google Scholar
27.
Ford  MK, Beattie  WS, Wijeysundera  DN.  Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index.  Ann Intern Med. 2010;152:26–35.Google Scholar
28.
Bertges  DJ, Goodney  PP, Zhao  Y,  et al.  The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients.  J Vasc Surg. 2010;52:674–683,683,e671–683,e673.Google Scholar
29.
Gupta  PK, Gupta  H, Sundaram  A,  et al.  Development and validation of a risk calculator for prediction of cardiac rise after surgery.  Circulation. 2011;26;124:381–387.Google Scholar
30.
Davis  C, Tait  G, Carroll  J,  et al.  The Revised Cardiac Risk Index in the new millennium: a singlecentre prospective cohort re-evaluation of the original variables in 9519 consecutive elective surgical patients.  Can J Anaesth. 2013;60:855–863.Google Scholar
31.
Bilimoria  KY, Liu  Y, Paruch  JL,  et al.  Development and Evaluation of the Universal ACS NSQIP Surgical Risk Calculator: A Decision Aid and Informed Consent Tool for Patients and Surgeons.  J Am Coll Surg. 2013;217:833–842.Google Scholar
32.
American College of Surgeons.  American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator.  Available at: http://riskcalculator.facs.org/PatientInfo/PatientInfo. Accessed: January 9, 2014.
33.
Hammill  BG, Curtis  LH, Bennett-Guerrero  E,  et al.  Impact of heart failure on patients undergoing major noncardiac surgery.  Anesthesiology. 2008;108:559–567.Google Scholar
34.
Welten  GM, Chonchol  M, Hoeks  SE,  et al.  Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.  Am Heart J. 2007;154:954–961.Google Scholar
35.
Beattie  WS, Abdelnaem  E, Wijeysundera  DN, Buckley  DN.  A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging.  Anesth Analg. 2006;102:8–16.  patients undergoing major vascular surgery.  Heart. 2003;89:1327–1334.Google Scholar
36.
Kertai  MD, Boersma  E, Bax  JJ,  et al.  A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery.  Heart. 2003;89:1327–1334.Google Scholar
37.
Wijeysundera  DN, Beattie  WS, Austin  PC,  et al.  Non-invasive cardiac stress testing before elective major noncardiac surgery: population based cohort study.  BMJ. 2010;340:b5526.Google Scholar
38.
Wijeysundera  DN, Duncan  D, Nkonde-Price  C,  et al.  Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.  J Am Coll Cardiol. 2014;64:2406–2425.Google Scholar
39.
Devereaux  PJ, Xavier  D, Pogue  J,  et al. POISE (PeriOperative ISchemic Evaluation) Investigators.  Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study.  Ann Intern Med. 2011;19;154:523–528.Google Scholar
40.
Devereaux  PJ, Chan  MT, Alonso-Coello  P,  et al; Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.  JAMA. 2012;307:2295–2304.Google Scholar
41.
Sandhu  A, Sanders  S, Geraci  SA.  Prognostic value of cardiac troponins in elderly patients with hip fracture--a systematic review.  Osteoporos Int. 2013;24:1145–1149.Google Scholar
42.
van Waes  JA, Nathoe  HM, de Graaff  JC  et al; Cardiac Health After Surgery (CHASE) Investigators.  Myocardial injury after noncardiac surgery and its association with short-term mortality.  Circulation. 2013;11;127:2264–2271.Google Scholar
43.
Beattie  WS, Karkouti  K, Tait  G,  et al.  Use of clinically based troponin underestimates the cardiac injury in noncardiac surgery: a single-centre cohort study in 51,701 consecutive patients.  Can J Anaesth. 2012;59:1013–1022.Google Scholar
44.
Levy  M, Heels-Ansdell  D, Hiralal  R,  et al.  Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and metaanalysis.  Anesthesiology. 2011;114:796–806.Google Scholar
45.
Kavsak  PA, Walsh  M, Srinathan  S,  et al.  High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study.  Clin Biochem. 2011;44:1021–1024.Google Scholar
46.
Weber  M, Luchner  A, Seeberger  M,  et al.  Incremental value of high-sensitive troponin T in addition to the revised cardiac index for perioperative risk stratification in noncardiac surgery.  Eur Heart J. 2013;34:853–862.Google Scholar
47.
Nagele  P, Brown  F, Gage  BF,  et al.  High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after non-cardiac surgery.  Am Heart J. 2013;166:325–332.e1.Google Scholar
48.
Goei  D, Schouten  O, Boersma  E,  et al.  Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.  Am J Cardiol. 2008;101:122–126.Google Scholar
49.
Karthikeyan  G, Moncur  RA, Levine  O,  et al.  Is a pre-operative brain natriuretic peptide or Nterminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and metaanalysis of observational studies.  J Am Coll Cardiol. 2009;54:1599–1606.Google Scholar
50.
Ryding  AD, Kumar  S, Worthington  AM, Burgess  D.  Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.  Anesthesiology. 2009;111:311–319.Google Scholar
51.
Rodseth  RN, Lurati Buse  GA.  The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis.  J Am Coll Cardiol. 2011;26;58:522–529.Google Scholar
52.
Rodseth  RN, Biccard  BM, Chu  R,  et al.  Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis.  Anesthesiology. 2013;119:270–283.Google Scholar
53.
Helwani  MA, Amin  A, Lavigne  P, Rao  S, Oesterreich  S, Samaha  E, Brown  JC, Nagele  P.  Etiology of Acute Coronary Syndrome after Noncardiac Surgery.  Anesthesiology. 2018 Jun;128(6):1084– 1091. PMID: PubMed.Google Scholar
54.
Pincus  D, Ravi  B, Wasserstein  D, Huang  A, Paterson  JM, Nathens  AB, Kreder  HJ, Jenkinson  RJ, Wodchis  WP.  Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery. JAMA.2017 Nov 28 ;318(20):1994–2003. PMID: PubMed.
55.
Levine  GN, Bates  ER, Bittl  JA, Brindis  RG, Fihn  SD, Fleisher  LA, Granger  CB, Lange  RA, Mack  MJ, Mauri  L, Mehran  R, Mukherjee  D, Newby  LK, O'Gara  PT, Sabatine  MS, Smith  PK, Smith  SC  Jr.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.  J Am Coll Cardiol. 2016 Sep 6 ;68(10):1082– 115. PMID: PubMed.Google Scholar
56.
Valgimigli  M, Bueno  H, Byrne  RA, Collet  JP, Costa  F, Jeppsson  A, Jüni  P, Kastrati  A, Kolh  P, Mauri  L, Montalescot  G, Neumann  FJ, Petricevic  M, Roffi  M, Steg  PG, Windecker  S, Zamorano  JL, Levine  GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).  Eur Heart J. 2018 Jan 14 ;39(3):213–260. PMID: PubMed.Google Scholar
57.
Chambers  JB.  Valve disease and non-cardiac surgery.  Heart. 2018 May 31 . pii: heartjnl-2017-312455. doi: 10.1136/heartjnl-2017-312455. [Epub ahead of print] PMID: PubMed.Google Scholar
58.
Wijeysundera  DN, Pearse  RM, Shulman  MA  et al. on behalf of the METS study investigators.  Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study.  Lancet. 391:2631-40. June 30 , 2018 DOI: 10.1016/S0140-6736(18)31131-0.Google Scholar
59.
Alrezk  R, Jackson  N, Al Rezk  M, Elashoff  R, Weintraub  N, Elashoff  D, Fonarow  GC.  Derivation and Validation of a Geriatric-Sensitive Perioperative Cardiac Risk Index.  J Am Heart Assoc. 2017 Nov 16 ;6(11). pii: e006648. PMID: PubMed.Google Scholar
60.
Duceppe  E, Parlow  J, MacDonald  P, Lyons  K, McMullen  M, Srinathan  S, Graham  M, Tandon  V, Styles  K, Bessissow  A, Sessler  DI, Bryson  G, Devereaux  PJ.  Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery.  Can J Cardiol. 2017 Jan;33(1):17–32. PMID: PubMed.Google Scholar
61.
Brown  JC, Samaha  E, Rao  S  et al.  Anesth Analg. 2017 Nov;125(5):1455–1462. PMID: PubMed.
62.
Devereaux  PJ, Biccard  BM, Sigamani  A  et al.  JAMA. 2017 Apr 25 ;317(16):1642–1651. PMID: PubMed.
63.
Puelacher  C, Lurati Buse  G, Seeberger  D,  et al; BASEL-PMI Investigators.  Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization.  Circulation. 2018 Mar 20 ;137(12):1221–1232. PMID: PubMed.Google Scholar
64.
Devereaux  PJ, Duceppe  E, Guyatt  G, Tandon  V, Rodseth  R, Biccard  BM, Xavier  D, Szczeklik  W, Meyhoff  CS, Vincent  J, Franzosi  MG, Srinathan  SK, Erb  J, Magloire  P, Neary  J, Rao  M, Rahate  PV, Chaudhry  NK, Mayosi  B, de Nadal  M, Iglesias  PP, Berwanger  O, Villar  JC, Botto  F, Eikelboom  JW, Sessler  DI, Kearon  C, Pettit  S, Sharma  M, Connolly  SJ, Bangdiwala  SI, Rao-Melacini  P, Hoeft  A, Yusuf  S; MANAGE Investigators.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.  Lancet. 2018 Jun 9 ;391(10137):2325–2334. doi: 10.1016/S0140-6736(18)30832-8. Erratum in:  Lancet. 2018 Jul 7 ;392(10141):30. PubMed PMID: PubMed.Google Scholar
65.
Adriaenssens  T, Sinnaeve  P.  Direct oral anticoagulants for postoperative myocardial injury.  Lancet. 2018 Jun 9 ;391(10137):2297–2298. doi: 10.1016/S0140-6736(18)30988-7. PubMed PMID:PubMedGoogle Scholar
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close